首页> 外国专利> METHOD FOR REPLACING MITOCHONDRIA AND CYTOPLASMA IN OOCYTES HAVING PATHOGENIC MUTATION OR CYTOPLASMIC INSUFFICIENCY

METHOD FOR REPLACING MITOCHONDRIA AND CYTOPLASMA IN OOCYTES HAVING PATHOGENIC MUTATION OR CYTOPLASMIC INSUFFICIENCY

机译:具有致突变性或细胞膜功能不全的卵母细胞中线粒体和细胞质的替代方法

摘要

The invention relates to biotechnology, in particular to genetic and cellular engineering, and can be used to replace mitochondria and cytoplasm in eggs by transplantation of meiotic chromosomes. The technical result is to increase the efficiency and safety in reproduction processes, minimizing the risks of mtDNA defects in the embryo. This is achieved by the fact that in the method of replacing mitochondria and cytoplasm in oocytes having a pathogenic mutation in mtDNA or cytoplasmic insufficiency, genetic testing is performed according to the invention to determine mtDNA from blood and / or fibroblasts of the skin and / or urine of a recipient mtDNA carrier having pathogenic mutation, the metaphase II spindle is isolated from the recipient oocyte of the mtDNA carrier having a pathogenic mutation or pathology in the cytoplasm, the metaphase II spindle is removed from the healthy donor oocyte, the metaphase II spindle from the recipient oocyte is transferred to the healthy donor's oocyte cell, the patient is injected recipient oocyte with a spindle transferred to obtain an embryo, the embryo is cultured with the formation of a blastocyst and pregnancy is established.
机译:本发明涉及生物技术,尤其涉及遗传和细胞工程,可通过减数分裂染色体的移植代替卵中的线粒体和细胞质。技术结果是提高繁殖过程的效率和安全性,将胚胎中mtDNA缺陷的风险降至最低。这是通过以下事实实现的:在替换在具有mtDNA致病性突变或胞质机能不全的卵母细胞中的线粒体和细胞质的方法中,根据本发明进行遗传测试以确定来自血液和/或皮肤的成纤维细胞和/或的mtDNA。具有致病突变的受体mtDNA载体的尿液,从细胞质中具有致病性突变或病理的mtDNA载体的受体卵母细胞分离出中期II纺锤体,从健康的供体卵母细胞中移除中期II纺锤体,中期II纺锤体从受体卵母细胞转移到健康供体的卵母细胞,给患者注入受体卵母细胞并转移纺锤体以获得胚胎,将胚胎培养成胚泡并建立妊娠。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号